Emc Capital Management Sangamo Therapeutics, Inc Transaction History

Emc Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $321,090 - $480,101	-61,394 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$10.17 - $12.64 $108,483 - $134,830	-10,667 Reduced 14.8%	61,394 $735,000
Q1 2021 May 05, 2021	BUY	$10.88 - $17.05 $250,990 - $393,326	23,069 Added 47.09%	72,061 $903,000
Q4 2020 Feb 24, 2021	BUY	$9.23 - $18.18 $452,196 - $890,674	48,992 New	48,992 $765,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.